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Distinct distribution of specific members of protein 4.1 gene One of the major functions of the kidney is to ensure
family in the mouse nephron. body homeostasis by balancing water and metabolite re-
Background. Protein 4.1 is an adapter protein that links the absorption and excretion, these events taking place inactin cytoskeleton to various transmembrane proteins. These
specialized regions of the nephron [1]. At the cellular4.1 proteins are encoded by four homologous genes, 4.1R, 4.1G,
level, a large part of this molecular traffic occurs through4.1N, and 4.1B, which undergo complex alternative splicing.
Here we performed a detailed characterization of the expres- specific transporters whose activity is mostly controlled
sion of specific 4.1 proteins in the mouse nephron. by various hormones and neuromediators [2]. Over the
Methods. Distribution of renal 4.1 proteins was investigated
past 10 years, there has been increasing evidence for reg-by staining of paraformaldehyde-fixed mouse kidney sections
ulation of the activity of ion transporters by the cytoskel-with antibodies highly specific for each 4.1 protein. Major 4.1
splice forms, amplified from mouse kidney marathon cDNA, eton [3–5]. Members of the protein 4.1 superfamily, such
were expressed in transfected COS-7 cells in order to assign spe- as ezrin, known to act as adapter proteins between the
cies of known exon composition to proteins detected in kidney. actin cytoskeleton and transmembrane proteins, haveResults. A 105 kD 4.1R splice form, initiating at ATG-2 trans-
been reported to play a key role in regulation of activitylation initiation site and lacking exon 16, but including exon
and trafficking of kidney transporters, such as the sodium17B, was restricted to thick ascending limb of Henle’s loop. A
95 kD 4.1N splice form, lacking exons 15 and 17D, was ex- proton exchanger NHE-3 [6–11]. The functional impact
pressed in either descending or ascending thin limb of Henle’s of such interactions has been further emphasized by the
loop, distal convoluted tubule, and all regions of the collecting
observation that NHEs are involved in organization ofduct system. A major 108 kD 4.1B splice form, initiating at a
cortical cytoskeleton and in control of cell shape inde-newly characterized ATG translation initiation site, and lacking
exons 15, 17B, and 21, was present only in Bowman’s capsule pendently of ion transport activity [12]. An important
and proximal convoluted tubule (PCT). There was no expres- discovery is that NHE regulation differs between proxi-
sion of 4.1G in kidney. mal and distal regions of the nephron [8]. It has beenConclusion. Distinct distribution of 4.1 proteins along the
proposed that this could result from differences in pro-nephron suggests their involvement in targeting of selected
tein scaffolds involved in cytoskeleton architecture. Suchtransmembrane proteins in kidney epithelium and, therefore,
in regulation of specific kidney functions. a hypothesis is supported by the observation that the
cytoskeletal proteins ankyrin and fodrin display differen-
tial distribution along the nephron [13–15]. This complex
spatial distribution likely results from the fact that each
of these cytoskeletal proteins is actually expressed as a
1 Dr. Walensky’s present address is Department of Cancer Immunology panel of isoforms encoded by highly related but distinct
and AIDS, Dana Farber Cancer Institute, Harvard Medical School, genes. For example, ankyrin is expressed as various iso-
Boston, Massachussetts 02115.
forms encoded by three homologous genes [16, 17]. Ex-
Key words: kidney, nephron, cytoskeleton, protein 4.1. pression of one of these ankyrin genes, Ank3, is mostly
restricted to epithelial tissues, such as kidney [14, 16–18].Received for publication August 26, 2002
An Ank3 isoform, AnkG190, has been reported to inter-and in revised form October 24, 2002
Accepted for publication November 21, 2002 act with a key kidney transporter, Na-K-ATPase [19].
Taken together, these studies have infused new interest 2003 by the International Society of Nephrology
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into evaluating the functional relevance of cytoskeletal METHODS
proteins in kidney. Surprisingly, characterization of renal Reagents
protein 4.1 has been overlooked so far, despite the fact All chemicals used in this study were of reagent grade.
that this protein, functionally related to ankyrin [17, 20]
Cell lines and miceand ezrin [21], is known to interact with key ion trans-
porters, such as the anion exchanger, AE1 [22–24]. Monkey kidney fibroblast (COS-7) cell line was from
Protein 4.1 was originally characterized in red blood American Type Cell Culture (Manassas, VA, USA). A
cells where it plays a key role in the regulation of me- strain of wild-type mice (129/SV) or 4.1R null mice gener-
ated by us as previously described [37] were bred on site.chanical stability [20]. Subsequent characterization in
nucleated cells demonstrated that protein 4.1 adopts a
Cloning of recombinant histidine (His)-taggedbroad cellular distribution [25], which results from the
4.1 proteinscombination of two factors. First, the protein 4.1 gene
cDNAs encoding full-length mouse 4.1R (initiatedundergoes complex alternative splicing of its pre-mRNA,
at ATG-1 and containing exon 17B-encoded peptide)resulting in translation of numerous splice forms from a
(Fig. 1), mouse 4.1G [29], mouse 4.1N [31], and mousesingle gene [26, 27]. Second, we, and others, have recently
4.1B [33], were cloned into pET31b() vector (Novagen,
characterized three additional protein 4.1 genes, 4.1G
Madison, WI, USA). Histidine (His)-tagged recombi-
[28, 29], 4.1N [30, 31], and 4.1B [32, 33], which are very nant 4.1 proteins, expressed in BL21 Gold (DE3) Esche-
homologous to the original red blood cell protein 4.1 richia coli (Stratagene, La Jolla, CA, USA), were purified
gene, renamed 4.1R in order to distinguish it from these according to the manufacturer’s instructions (Nova-
new genes. Importantly, the splicing of protein 4.1R is gen), with the following modification. Because of their
tissue-specific, developmentally regulated, and also in- insolubility, proteins were extracted in binding buffer
fluenced by cellular interactions with the extracellular supplemented with 6 mol/L urea. After affinity purifica-
matrix [34]. As expected from its broad cellular distribu- tion, proteins were dialyzed against phosphate-buffered
saline (PBS).tion, protein 4.1R interacts with a growing list of binding
partners located throughout the cell [20, 35]. The func-
Protein 4.1 antibodiestional impact of potential interactions between protein
Antibodies were raised against recombinant proteins4.1R, or its homologs, and ion transporters and tight
or peptides encoded by unique regions of mouse 4.1R,junction proteins [36], has yet to be defined.
4.1G, 4.1N, or 4.1B (Fig. 1). Mouse 4.1R, 4.1G, and 4.1NAs a first and necessary step to investigate the func-
antibodies were raised in rabbit against recombinant His-tional relevance of protein 4.1 in kidney epithelium, we
tagged proteins corresponding to mouse 4.1R exon 13-performed a detailed characterization of the expression
encoded peptide, mouse 4.1R exon 17B-encoded pep-of the four 4.1 proteins in this tissue. Immunohistochem-
tide, mouse 4.1G unique region U1 [29], part of mouse
istry studies show specific tissue and cellular distributions 4.1G unique region U3 [38], or mouse 4.1N unique region
for each renal 4.1 protein. Amplification of kidney 4.1 U1 [31]. Mouse 4.1B antibody was raised in goat against
cDNAs reveals that each 4.1 protein exists as various a 20 amino acid residue peptide within the unique region
splice forms and, consistent with this observation, renal U2 [33]. We also used four antibodies raised in rabbit
4.1 proteins are expressed as various protein isoforms in against either human 4.1R unique region U1, a 21 amino
vivo. The findings outlined here establish a foundation acid residue peptide encoded by human 4.1R exon 16
for identifying renal 4.1 protein binding partners, and [39], a 34 amino acid residue peptide encoded by human
for determining the roles of 4.1 proteins in kidney struc- 4.1R exon 19 [39], or a 20 amino acid residue peptide
corresponding to the very last amino acids encoded byture and function.

Fig. 1. Exon maps of mouse 4.1 protein genes and corresponding protein domains. Maps show exon composition and corresponding protein
domains for the four mouse 4.1 genes, 4.1R, 4.1G, 4.1N, and 4.1B (maps for mouse 4.1N and 4.1B genes are derived from corresponding human
genes). Exons in gray are constitutive, those in black alternative, and those in white noncoding. Three conserved protein domains, the membrane
binding domain (MBD), the spectrin-actin binding domain (SAB), and the C-terminal domain (CTD), and the corresponding regions in 4.1G,
4.1N, and 4.1B, with percentage of homology with 4.1R, are displayed in white. The SAB domain is nonconserved (nc) in 4.1N. The regions in
gray, interspersed with conserved domains, are poorly conserved among 4.1 proteins (unique regions U1, U2, and U3). Note that the maps display
all exons known so far for each 4.1 gene, regardless of their tissue-specific expression. Some exons, in particular in the unique U2 and U3 regions
and in the SAB domain, may be omitted in the tissues that we referred to in the present study (i.e., brain, spleen, or kidney). The figure also
shows location of the peptides used to raise antibodies specific for each protein 4.1 gene product: RU1, RE13, RE16, RE17B, RE19, and RE21
for 4.1R; GU1 and GU3 for 4.1G; NU1 for 4.1N; and BU2 for 4.1B.
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human 4.1R exon 21 [39]. All antibodies, except for tissue extracts. Kidneys, spleen, and brain were homoge-
nized in 5 mL cold lysis buffer [perfusion buffer containingmouse 4.1R exon 17B–encoded peptide antibody, were
affinity purified. Specificity of protein 4.1 antibodies was 1% (octylphenoxy)polyethoxyethanol (Sigma Aldrich)].
Aliquots were kept for protein assay, while lysates wereassessed by comparing their reactivity against 100 ng
of each of the four recombinant His-tagged full-length denatured in Tris-glycine sample buffer containing so-
dium dodecyl sulfate (SDS) and 100 mmol/L dithiotreitolmouse 4.1 proteins described in the previous section.
Processing of the corresponding Western blots is de- and used for Western blotting.
scribed below.
Western blotting
Immunohistochemistry Samples were run on 8% Tris-glycine gels (Invitro-
gen, Carlsbad, CA, USA) and gels were transferred ontoMouse kidney sections were processed for immunohis-
tochemistry as previously described [40] with some modi- Immobilon-P polyvinylidene fluoride membranes (Mil-
lipore Corp., Bedford, MA, USA). Membranes werefications. Mice were anesthetized, perfused with 10 mL
perfusion buffer in order to exsanguinate tissues, then blocked for 1 hour at room temperature in blotting buffer
[PBS  1% Tween-20  4% nonfat dry milk  1%with 10 mL PBS containing 4% paraformaldehyde in
order to fix tissues in vivo. Kidneys were harvested, cryo- bovine serum albumin (BSA) 1% donkey serum], then
incubated overnight at 4C with primary 4.1 antibodiespreserved in PBS  sucrose, and flash frozen in liquid
nitrogen. Kidney cryosections (10m thick) were stained diluted at 0.1 to 0.3g/mL (mouse 4.1R exon 17B peptide
antibody diluted 1:3000) in blotting buffer. After exten-overnight at 4C with specific 4.1 antibodies diluted 1/25
(anti-4.1R E19 antibody) or 1:10 (anti-4.1N U1 and 4.1B sive washes in PBS  1% Tween-20, membranes were
reblocked for 15 minutes in blotting buffer without don-U2 antibodies), then for 2 hours at room temperature
with either antirabbit immunoglogulin G (IgG) (4.1R key serum, then incubated for 1 hour at room tempera-
ture with either biotinylated donkey antirabbit IgGsand 4.1N) or antigoat IgGs (4.1B) coupled to Cy3 (Jack-
son Laboratories, West Grove, PA, USA) diluted 1:200. (Amersham Pharmacia Biotech., Piscataway, NJ, USA),
for 4.1R, 4.1G, and 4.1N blots, or biotinylated donkeyIn experiments where both 4.1 and aquaporin-2 (AQP-2),
a specific marker for principal cells in collecting duct antigoat IgGs, for 4.1B blot, diluted 1:500 in blotting
buffer without serum. After extensive washes, mem-[41], were detected, and since antibodies for both anti-
gens were rabbit polyclonal antibodies, kidney sections branes were reblocked for 15 minutes with complete
blotting buffer, and incubated for 1 hour at room temper-were first stained with 4.1 antibody as described above,
then incubated for 1 hour at room temperature with ature with streptavidin coupled to horseradish peroxi-
dase (Amersham Pharmacia Biotech.), diluted 1:40,000rabbit IgGs diluted 1:10, 1 hour at room temperature
with antirabbit Fab fragments (Jackson Immunoresearch in blotting buffer. After extensive washes, membranes
were processed with chemiluminescent Renaissance re-Laboratories, Inc., West Grove, PA, USA) diluted 1:50,
then stained overnight at 4C with anti-AQP-2 antibody agent (NEN) (Dupont, Boston, MA, USA). Blots used to
assess antibody cross-reactivity were processed as above[42] diluted 1:100, followed by secondary antirabbit IgGs
coupled to Alexa 488 (Molecular Probes, Eugene, OR, except that recombinant His-tagged full-length mouse
proteins 4.1R, 4.1N, 4.1B, and 4.1G were run on 6%USA) diluted 1:100. In experiments where both 4.1 and
the Tamm-Horsfall protein, a specific marker for the Tris-glycine gels. In order to confirm purity and equal
loading of the recombinant proteins, recombinant pro-thick ascending limb of Henle’s loop [43], were detected,
kidney sections were first stained with 4.1 antibody then teins normalized after protein assay were run on a gel
and stained with Gelcode blue stain reagent (Pierce,with Tamm-Horsfall protein antibody (Valbiotech, Paris,
France) diluted 1:50, followed by antigoat IgGs coupled Rockford, IL, USA). Control blots were probed with
either preimmune rabbit (for 4.1R, 4.1N, and 4.1G anti-to fluorescein isothiocyanate (FITC) (Nordic Immuno-
logical Laboratories, Tilburg, The Netherlands) diluted bodies), or goat (for 4.1B antibody) serums. In experi-
ments designed to assess specificity of detection of renal1:50. Sections were mounted and observed with a Zeiss
LSM 510 confocal microscope (Zeiss, Inc., Oberkochen, 4.1 proteins, blots were processed as described above ex-
cept that primary 4.1 antibodies were preadsorbed orGermany).
not prior to dilution in blotting buffer and incubation
Preparation of tissue extracts with polyvinylidine difluoride (PVDF) membranes. Briefly,
anti-4.1R E13, anti-4.1R E19, anti-4.1N U1, and anti-129/SV strain wild-type or 4.1R null mice were per-
fused with 10 mL PBS containing 1 mmol/L ethylene 4.1B U2 antibodies were incubated for 2 hours at 4C
with either PBS or PBS containing a 10 molar excess ofglycol tetraacetate (EGTA), 1 mmol/L difluoroisopro-
pylfluorophosphate, and a cocktail of protease inhibitors either recombinant His-tagged full-length mouse 4.1R
for anti-4.1R E13 and anti-4.1R E19 antibodies, full-(Sigma-Aldrich, St. Louis, MO, USA) (perfusion buffer)
in order to minimize red blood cell contamination in length mouse 4.1N for anti-4.1N U1 antibody, or full-
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length mouse 4.1B for anti-4.1B U2 antibody (4.1G was acid sequence between the four 4.1 proteins, we raised
antibodies against unique regions of each 4.1 protein tonot tested in these latter assays because of its lack of
expression in kidney). ensure specificity of protein detection (Fig. 1). Antibody
specificity was investigated by probing each antibody
Protein assay against the four recombinant full-length mouse 4.1 pro-
teins expressed in E. coli. Most antibodies reacted pre-Protein assays were performed using detergent com-
patible protein reagent (Bio-Rad, Hercules, CA, USA) dominantly with their corresponding recombinant 4.1
protein (Fig. 2 and Table 1). Three antibodies showedwith BSA as a standard.
strong cross-reactivity: anti-4.1R E16 antibody with 4.1G,
5 rapid amplification of cDNA ends (RACE) and anti-4.1R E21 antibody with 4.1N, 4.1B and 4.1G, and
3 RACE of renal 4.1 genes anti-4.1G U3 antibody with 4.1R, 4.1N, and 4.1B, respec-
tively (Fig. 2). Because of their extensive lack of specific-Splicing events taking place either in the 5 half or in
the 3 half of each 4.1 protein gene were investigated by ity, anti-4.1R E21 and anti-4.1G U3 antibodies were not
used in the study. Three antibodies showed weak cross-amplifying mouse kidney marathon cDNA by polymer-
ase chain reaction (PCR) according to the manufactur- reactivity: anti-4.1R E13 antibody with 4.1N, 4.1B, and
4.1G, anti-4.1R E19 antibody with 4.1B and anti-4.1Ner’s instructions (BD Biosciences-Clontech, Palo Alto,
CA, USA). The AP1 primer, specific for the adapters U1 antibody with 4.1R, 4.1B, and 4.1G, respectively (Ta-
ble 1). Such weak signals could only be detected afterflanking marathon cDNAs, was used in combination with
either reverse primers (5 RACE), or forward primers long exposure of the blots, leading to a saturation of the
signal obtained with the protein reacting strongly with(3 RACE), specific for each protein 4.1 gene (Table
2). The 4.1 gene specific primers were chosen in the the antibody. Therefore, as extensively shown in this
study, these weak cross-reactivities did not end up beingmembrane binding domain (MBD) region, a region sub-
ject to very few alternative splicing events. very relevant.
Having investigated antibody specificity, we probed
Amplification of renal 4.1 full-length coding regions paraformaldehyde-fixed mouse kidney sections with se-
lected antibodies highly specific for each 4.1 protein (i.e.,Full-length 4.1 protein splice forms were amplified by
PCR from mouse kidney marathon cDNA, using pairs anti-4.1R E19, anti-4.1N U1, anti-4.1B U2, and anti-4.1G
U1 antibodies). Kidney 4.1R showed strong expressionof protein 4.1 gene-specific primers designed in light of
the information obtained from 5 RACE and 3 RACE in cortex and outer medulla, but poor expression in inner
medulla (Fig. 3A, first row, three left panels). The proteinexperiments. Forward primers bear a HindIII restriction
site, while reverse primers bear either a Xho I (in the showed obvious basolateral expression (Fig. 3A, first row,
left panel, inset). Specificity of detection of protein 4.1Rcase of 4.1R and 4.1B) or a Sal I (in the case of 4.1N
and 4.1G) restriction site in order to allow subsequent was confirmed by the lack of signal in 4.1R null kidney,
in contrast to the presence of staining in wild-type kidneycloning of PCR products into C-terminal hemagglutinin
(HA)–tagged mammalian expression vector pCDNA3 (Fig. 3A, compare left and right panels of first row for an
example in outer medulla). This observation supported(Invitrogen) as previously described [25, 33, 44].
that anti-4.1R E19 antibody was unable to interact with
COS-7 cell transfection 4.1B in kidney sections, despite its weak cross-reactivity
with recombinant 4.1B (Table 1). The distribution of 4.1RCOS-7 cells were transfected with cDNAs encoding
major renal HA-tagged 4.1 protein splice forms as pre- was the same as that of Tamm-Horsfall protein (Fig. 3B;
left panel and middle panel for magnification), a specificviously described [25, 33, 44] with minor modifications.
Briefly, cells grown in 100 mm cell culture dishes were marker for the thick ascending limb of Henle’s loop [43].
In contrast, 4.1R did not co-localize with water channeltransfected with 12 g DNA and 36 L lipofectamine
2000 according to the manufacturer’s instructions (Invi- AQP-2 (Fig. 3C, left panel), a specific marker for princi-
pal cells in collecting duct [41]. Kidney 4.1N showedtrogen). After 24 hours of transfection, cells were washed
twice with PBS, then denatured and processed for West- strong expression in cortex, outer medulla, and inner
medulla (Fig. 3A, second row, three left panels). Theern blotting as described above.
protein was found in the thin limb of Henle’s loop, distal
convoluted tubule (DCT), and all regions of the collect-
RESULTS
ing duct system [i.e., cortical collecting duct (CCD),
Distinct distribution of 4.1 proteins in kidney outer medullary collecting duct (OMCD), and inner
medullary collecting duct (IMCD)]. Specific detectionAs a first step toward characterizing 4.1 proteins in
kidney, we investigated their distribution within the tis- of 4.1N was supported by the fact that protein expression
was similar in wild-type and 4.1R null kidney (Fig. 3A,sue by staining mouse kidney sections with various pro-
tein 4.1 antibodies. Given the very high identity of amino compare left and right panels of second row for an exam-
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Fig. 2. Specificity of 4.1 protein antibodies as-
sessed by reactivity with recombinant histad-
ine (His)-tagged full-length mouse proteins
4.1R, 4.1N, 4.1B, and 4.1G. Antibodies raised
against recombinant proteins or peptides en-
coding various regions of human 4.1R (anti-
4.1R U1, anti-4.1R E16, anti-4.1R E19 and
anti-4.1R E21) or mouse 4.1R (anti-4.1R E13
and anti-4.1R E17B), mouse 4.1G (anti-4.1G
U1 and anti-4.1G U3), mouse 4.1N (anti-4.1N
U1), and mouse 4.1B (anti-4.1B U2), were
probed against 100 ng of recombinant His-
tagged full-length mouse proteins 4.1R, 4.1N,
4.1B, and 4.1G, as described in the Methods
section. Equal loading of recombinant pro-
teins was confirmed after protein assay and
staining of a gel with Gelcode blue stain re-
agent. Most antibodies reacted predominantly
with their corresponding 4.1 protein. Three
antibodies showed strong cross-reactivity:
anti-4.1R E16 antibody with 4.1G, anti-4.1R
E21 antibody with 4.1N, 4.1B, and 4.1G, and
anti-4.1G U3 antibody with 4.1R, 4.1N, and
4.1B, respectively. Three antibodies showed
weak cross-reactivity: anti-4.1R E13 antibody
with 4.1N, 4.1B, and 4.1G, anti-4.1R E19 anti-
body with 4.1B and anti-4.1N U1 antibody
with 4.1R, 4.1B, and 4.1G, respectively (Table
1). Such weak signals could only be detected
after long exposure of the blots, leading to
a saturation of the signal obtained with the
protein reacting strongly with the antibody
(data not shown). Therefore, as extensively
shown in this study, these weak cross-reactivi-
ties should not be considered as very relevant.
Molecular weight protein markers expressed
in kD are shown on the left of each panel.
The information gathered through this West-
ern blot analysis is summarized in Table 1.
Table 1. Assessment of antibody specificity against 4.1 recombinant proteins
Mouse 4.1R Mouse 4.1N Mouse 4.1B Mouse 4.1G
Anti-4.1R U1 region (RU1)  0 0 0
Anti-4.1R exon 13 (RE13)  / / /
Anti-4.1R exon 16 (RE16)  0 0 
Anti-4.1R exon 17B (RE17B)  0 0 0
Anti-4.1R exon 19 (RE19)  0 / 0
Anti-4.1R exon 21 (RE21)    
Anti-4.1N U1 region (NU1) /  / /
Anti-4.1B peptide exon 13 (BU2) 0 0  0
Anti-4.1G U1 region (GU1) 0 0 0 
Anti-4.1G U3 region (GU3)    
Antibodies against recombinant proteins or peptides encoding unique regions of mouse 4.1R, 4.1G, 4.1N, and 4.1B were tested against 100 ng of full-length
recombinant mouse 4.1R, initiated at ATG-1 and expressing exon 17B-encoded peptide, 4.1G [30], 4.1N [32] and 4.1B [34] as described in the Methods section. Each
antibody reacted strongly with its corresponding protein. Some antibodies reacted at various extents with the three other 4.1 proteins. We want to emphasize that
most weak cross-reactivities listed in this table do not appear on the Western blots presented in Figure 2. This is because such weak signals can only be detected
after long exposure of the blots, leading to saturation of the signal obtained with the protein reacting strongly with the antibody. Therefore, as extensively shown
in this study, these weak cross-reactivities (labeled /) should not be considered as very relevant. The following grading system was based on immunoblot reactivity:
, strong reactivity; , significant reactivity; /, weak reactivity; 0, no reactivity.
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ple in outer medulla). This observation was in accor- ATG-1 [26, 27]. Thus, translation of kidney 4.1R was
only initiated at the downstream ATG-2 site located indance with the absence of cross-reactivity of anti-4.1R
E19 antibody with recombinant 4.1N (Fig. 2), and the exon 4 [26, 27]. 3RACE experiments, using primer AP1
and a mouse 4.1R-specific forward primer (Table 2), didvery weak cross-reactivity of anti-4.1N U1 antibody with
recombinant 4.1R (Table 1). Like 4.1R, 4.1N was dis- not detect any unexpected structures in the 3 region of
the 4.1R transcripts. Amplification of full-length kidneytinctly expressed at the basolateral pole (Fig. 3A, second
row, left panel, inset). However, unlike 4.1R, 4.1N did 4.1R coding region, using a forward primer in the ATG-2
region in exon 4, and a reverse primer specific for thenot localize in the same structures as Tamm-Horsfall
protein (i.e., in thick ascending limb of Henle’s loop end of the coding region encoded by exon 21, resulted
in amplification of two PCR products of 2300 bp and(Fig. 3B, right panel). Co-staining of 4.1N and water
channel AQP-2 revealed that 4.1N was present in collect- 1850 bp (Fig. 5). The predominant 2300 bp PCR product
included exon 17B, a 450 bp exon specifically expresseding duct, with protein expression in both intercalated
and principal cells (Fig. 3C, middle panel and right panel in epithelial tissues [34]. Sequence analysis of individual
subclones derived from this PCR product further showedfor magnification). Thus, 4.1R and 4.1N have distinct
distributions within the kidney. Interestingly, the most re- that it was actually a mixture of two splice forms differing
by either inclusion or exclusion of exon 16, a 63bp exonstricted distribution was observed for 4.1B. 4.1B showed
strong expression in cortex but no expression in either located within the spectrin actin binding (SAB) domain
[26, 27]. Most of the clones excluded this exon (28 outouter or inner medulla (Fig. 3A, third row). 4.1B expres-
sion was similar in wild-type and 4.1R null kidney cortex of 33 clones). These two species could not be visually
discriminated within the 2300 bp PCR product due to the(Fig. 3A, third row, compare left and right panels), em-
phasizing the specificity of detection of 4.1B as expected small size of exon 16. The minor 1850 bp PCR product
excluded exon 17B. This product also comprised a mix-from the absence of cross-reactivity of the anti-4.1B U2
antibody with 4.1R, 4.1N and 4.1G (Fig. 2). 4.1B expres- ture of two splice forms including or excluding exon 16,
with a majority of the clones (15 out of 19 clones) oncesion appeared diffuse in Bowman’s capsule, where it
seemed to be restricted to parietal cells (Fig. 3A, third again lacking this exon. All clones lacked exons 14 and
15, and all but one clone lacked exon 17A [45, 46]. Takenrow, left panel). 4.1B was present mostly in the basolat-
eral pole of proximal convoluted tubule (Fig. 3A, third together, these data led us to conclude that the major
kidney 4.1R isoform was initiated at ATG-2, and that itrow, left panel), although some proximal convoluted tu-
bules showed strong apical staining (Fig. 3A, third row, included all exons of the coding region except exons 2,
14, 15, 16, and 17A (Fig. 6).left panel, lower inset). Using our antibodies, we were
unable to detect 4.1G by immunostaining, an observation Mouse kidney 4.1N. Neither 5 RACE nor 3 RACE
experiments, using primer AP1 and either a mouse 4.1N-confirmed by Western blotting experiments (see below).
These data clearly show distinct distributions of 4.1 specific reverse primer or a mouse 4.1N-specific forward
primer, respectively (Table 2), revealed any splicingproteins along the various segments of the nephron, as
summarized in Figure 4. The dramatic heterogeneity in event that could alter kidney 4.1N translation at the very
5 or 3 end of the coding region. Amplification of full-the distribution of 4.1 proteins within the kidney epithe-
lium strongly supported the hypothesis that each 4.1 length mouse kidney 4.1N coding region generated two
PCR products of 2550 bp and 2150 bp (Fig. 5). Theprotein might play distinct roles in kidney structure and
function. However, it became clear that it was critical predominant 2150 bp species lacked (1) a 36 bp exon
located in unique region U2 (Fig. 1) and sharing highto decipher the structure of renal 4.1 proteins prior to
implementing such functional investigations. homology with mouse 4.1B exon 15 [33], and (2) a 408
bp exon in unique region U3 assigned to exon 17D (Fig.
Multiple 4.1 protein cDNAs are expressed in kidney 1). These two exons were present in the minor 2550 bp
species. A minor splicing event consisted of exclusion ofIn order to deduce the primary structure of the major
renal 4.1 proteins, we used PCR techniques to amplify exon 20 (1 out of 8 clones). Taken together, these data
showed that kidney 4.1N was differing from brain 4.1N4.1 sequences from mouse kidney marathon cDNA (see
Methods section). Due to the complex structure of the by exclusion of both exons 15 and 17D (Fig. 6).
Mouse kidney 4.1B-5 RACE experiments, using primer4.1 genes, including the potential for multiple 5 and 3
ends [26–27, 30, 33], accurate characterization required AP1 and a mouse 4.1B-specific reverse primer (Table 2),
revealed that the predominant isoform of 4.1B in mouseboth 5 and 3 RACE experiments prior to amplification
of full-length coding regions. kidney possessed a 5 structure distinct from the pub-
lished cDNA from mouse brain [33]. Whereas the brainMouse kidney 4.1R-5 RACE experiments, using primer
AP1 and a mouse 4.1R specific reverse primer (Table 2), form of 4.1B cDNA initiated translation at an ATG in
a novel exon 2–like region near the 5 end of the tran-revealed that kidney 4.1R lacked exon 2, a 17 bp exon
that includes the upstream translation initiation site script, kidney 4.1B cDNAs were mostly spliced so as to
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Fig. 3. Tissue distribution of 4.1 proteins in kidney. Wild-type or 4.1R null mouse kidney sections were stained with antibodies specific for each
4.1 protein as described in the Methods section. (A) Kidney sections were stained with either anti-4.1R E19 antibody (first row), anti-4.1N U1
antibody (second row), or anti-4.1B U2 antibody (third row). As expected from 4.1 protein distribution in wild-type kidney, 4.1R showed no signal
in any 4.1R null kidney section (shown only for outer medulla), while 4.1N showed signal in all 4.1R null sections (shown only for outer medulla),
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delete this sequence. Therefore, kidney 4.1B was pre-
dicted to lack the N-terminal U1 region characteristic of
brain 4.1B [33]. We hypothesized that, like for 4.1R,
translation of 4.1B might be initiated at a further down-
stream ATG site, whose position was analogous to ATG-2
in the 4.1R gene (Fig. 1) [26, 27]. Transfection experi-
ments with 4.1B expression plasmids confirmed this hy-
pothesis (see below). 3 RACE experiments, using AP1
primer and a mouse 4.1B-specific forward primer (Ta-
ble 2), confirmed that exon 21, a 117 bp exon that encodes
the last 36 amino acids of the coding region, the stop
codon and the first 6 bp of the 3UTR region, was pre-
dominantly omitted in kidney [33]. This resulted in a trun-
cated splice form including exon 20 followed by exon 22
which encodes a glutamic acid residue and a stop codon.
Amplification of full-length mouse kidney 4.1B coding
region, using a ATG-2 specific forward primer and a
reverse primer annealing to exons 20 and 22, resulted in
two PCR products, a major 2100 bp product and a minor
1900 bp product (Fig. 5). Analysis of these products led Fig. 4. Distribution of 4.1 proteins along the nephron. The schematic
diagram displays identity of renal 4.1 proteins and their distributionto the characterization of three splice forms. All three
along the nephron: 4.1B in Bowman’s capsule and proximal convoluting
species showed concomitant exclusion of a 36 bp exon tubule, 4.1R in thick ascending limb of Henle’s loop, 4.1N in thin limb
and a 123 bp exon, which we assigned to exon 15 and of Henle’s loop, distal convoluted tubule, cortical collecting duct, outer
medulla collecting duct, and inner medulla collecting duct. Because theexon 17B, respectively (Fig. 1). We previously reported
4.1N antibody does not stain all thin limb sections in kidney sections,
exclusion of exon 15 [33]. The major isoform lacked exons and in the absence of specific markers for either the thin descending
15 and 17B. A second splice form also excluded a 54 bp limb or the thin ascending limb, we cannot conclude which of these
two structures 4.1N is expressed.stretch, corresponding to the beginning of exon 13, a
splicing event previously reported in brain 4.1B [47].
Further PCR screening using primers surrounding the
spliced region in exon 13 showed that inclusion of this
Mouse kidney 4.1G. Although 4.1G was not detected
54 bp region was the more predominant event (data not
in immunohistochemistry experiments, we wanted toshown). Because of the small difference in overall size
check first, whether 4.1G cDNA species could be identi-between these two splice forms, resulting from either
fied in kidney, and, second, whether such cDNA struc-inclusion or exclusion of the 54 bp region in exon 13,
tures, if any, could be detected or not as proteins bythey could not be visually discriminated within the 2100
Western blotting. Neither 5RACE nor 3RACE exper-bp PCR product (Fig. 5). A minor third splice form
iments, using primer AP1 and either a mouse 4.1G spe-lacked 192 bp exon 17 in addition to partial skipping of
cific reverse primer or a mouse 4.1G-specific forwardexon 13 and to exclusion of exons 15 and 17B. This latter
primer, respectively (Table 2), revealed any splicing eventisoform was likely to correspond to the 1900 bp PCR
that could affect translation at the very 5 end or 3 end ofproduct (Fig. 5), given the size of exon 17. Taken to-
kidney 4.1G. Amplification of full-length kidney mousegether, these data demonstrated that translation of the
4.1G coding region, using a forward primer correspond-major kidney 4.1B isoform was initiated at an ATG-2
ing to the beginning of mouse 4.1G coding region insite, and that this splice form lacked exons 15 and 17B
exon 2 and a reverse primer specific for the end of mouseand was terminated shortly after exon 20 (Fig. 6). An-
4.1G coding region in exon 21, generated two PCR prod-other important splice form also lacked a 54 bp region
in exon 13 (Fig. 6). ucts of 2950 bp and 2750 bp, both expressed at similar

and 4.1B only in cortical 4.1R null sections. Insets in left panel of first and second row highlight basolateral expression of 4.1R and 4.1N, respectively.
Nuclei (in green) were stained with sytox in these sections. Insets in first left panel of third row highlight 4.1B diffuse expression in Bowman’s
capsule (BC) (upper inset) and apical expression in some proximal convoluting tubules (PCT) (lower inset). (B) Wild-type mouse kidney sections
were stained with anti protein Tamm-Horsfall antibody, a specific marker for thick ascending limb of Henle’s loop (TAL), and either anti-4.1R
E19 antibody (two panels from the left) or anti-4.1N U1 antibody (right panel). (C) Wild-type mouse kidney sections were stained with anti-
aquaporin-2 (AQP-2) antibody, a specific marker for collecting duct, and either anti-4.1R E19 antibody (left panel) or anti 4.1N U1 antibody (two
panels from the right). Abbreviations are: CCD: cortical collecting duct; cTAL: cortical thick ascending limb of Henle’s loop; IMCD: inner medullary
collecting duct; mTAL: medullary thick ascending limb of Henle’s loop; and OMCD: outer medullary collecting duct. Scale bar, 100 m.
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Table 2. List of 4.1 gene specific primers used for 5 RACE and 3 RACE experiments
Gene Type of experiment Primer sequence Exon location
4.1R 5 RACE 5-AATGTTCTTGCTCTCCAGGCCGGAT Exons 11-10
4.1R 3 RACE 5-GCAGCAGCTTCTTCATCAAGATCCG Exon 10
4.1G 5 RACE 5-TCCACACACACCTTCCATAGCCGTT Exon 11
4.1G 3 RACE 5-CACCACAATTTGAGCGTGCCTCTAGT Exon 12
4.1N 5 RACE 5-TCAAGGCTGCGGGACATGGTATAGC Exon 12
4.1N 3 RACE 5-CCTCAGTCAGTGAGAATCACGATGC Exon 13
4.1B 5 RACE 5-GAGAGATGCCCTTTGTTGTGGCGTA Exon 13
4.1B 3 RACE 5-AGAAAAAGGCTGAAGAGGAGCGCGT Exon 13
Features of 4.1 gene specific reverse primers used for 5 RACE and forward primers used for 3 RACE experiments are presented. Primers were optimized using
MacVector software version 6.0 (Oxford Molecular Ltd., Oxford, England), [i.e., selected in particular for a high melting temperature (65C)] in order to minimize
non specific PCR amplification of mouse kidney marathon cDNA.
Fig. 5. Characterization of kidney-specific protein 4.1 cDNA splice forms. Full-length 4.1 protein coding regions were amplified from mouse
kidney marathon cDNA using pairs of primers specific for each 4.1 gene (see Methods section). Location of primers used for polymerase chain
reaction (PCR) amplification and resulting PCR products are shown for each 4.1 gene. Size of each PCR product expressed in base pair (bp) is
displayed. Abbreviations are: CTD, C-terminal domain; MBD, membrane binding domain; and SAB, spectrin-actin binding domain.
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Fig. 6. Maps of major protein 4.1 kidney splice forms. Exonic map and protein structure is displayed for each major renal 4.1 isoform identified
by polymerase chain reaction (PCR) screening: 105 kD kidney 4.1R, 95 kD kidney 4.1N, 108 and 105 kD kidney 4.1Bs. The 108 kD 4.1B isoform
expresses the 18 amino acids encoded by the 54 bp region shown in black in exon 13, while the 105 kD isoform does not. Constitutive exons are
shown in gray, alternative exons in black and non coding exons in white. Abbreviations are: CTD, C-terminal domain; MBD, membrane binding
domain; and SAB, spectrin-actin binding domain.
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levels (Fig. 5). Sequencing of these PCR products re- kidney 4.1R isoform, they were still expressed in 4.1R
null kidney extract (Fig. 7, panel anti-4.1B U2), empha-vealed that the 2950 bp band corresponded to the proto-
typical mouse 4.1G isoform previously described [29], sizing that they were truly the distinct 4.1B isoforms, an
expected observation given the very high specificity ofwhile the 2750 bp band lacked both exons 16 and 17.
Minor splicing events consisted of inclusion of exon 17C the anti-4.1B U2 antibody (Fig. 2). Of particular note, all
antibodies tested, including rabbit and goat preimmune(1 out of 16 clones), and exclusion of exon 19 (1 out of
16 clones) (Fig. 1). Taken together, these data indicated antibodies (Fig. 7, panels PI Rab and PI goat, respec-
tively), showed a band migrating at 130 kD in kidneythat the two major kidney 4.1G isoforms would be the
prototypical isoform already described [29], and an iso- (marked with an asterisk in all blots). This protein, de-
tected in kidney (Fig. 7, panels anti-4.1R E13 to E16),form excluding both exons 16 and 17, a region encoding
a SAB domain [48] similar to that described in 4.1R [49]. was absent in spleen and brain (Fig. 7, panel anti-4.1R
E13 and panels anti-4.1N U1 and anti-4.1B U2, respec-However, these two species did not contribute to signifi-
cant 4.1G protein expression in kidney (see previous tively). This nonspecific band seen on Western blots did
not confound immunohistochemical findings showingsection).
the complete lack of background staining in 4.1R null
Specific 4.1 proteins isoforms are expressed in kidney mice (Fig. 3). Protein 4.1G, probed with anti-4.1G U1
antibody [29], was barely detectable (data not shown),The complexity of the structure of kidney 4.1 cDNAs
was confirmed at the protein level. We probed whole confirming our immunohistochemistry experiments. Im-
portantly, the absence of 4.1G in kidney validated thekidney extracts with antibodies specific for each 4.1 pro-
tein (Fig. 7). Whole spleen and brain extracts were used use of anti-4.1R E16 antibody to study specific kidney
4.1R isoforms, the cross-reactivity of this 4.1R antibodyas “positive control tissues” for high level of expression
of either 4.1R, or of 4.1N, 4.1G, and 4.1B, respectively with 4.1G not being an issue in kidney.
In order to assess further the specificity of detection(Fig. 7). The use of four 4.1R specific antibodies revealed
that kidney 4.1R was expressed as a major 105 kD iso- of kidney 4.1 proteins and to definitely rule out that the
130 kD protein reacting with all antibodies tested in thisform, with minor isoforms migrating at 70 to 75 kD
(Fig. 6, panel anti-4.1R E13 to E16). The specificity of study was a 4.1 isoform (Fig. 7), wild-type mouse whole
kidney extracts were probed with four representative 4.1these bands as true protein 4.1R isoforms was supported
by their absence in kidney extracts prepared from 4.1R antibodies, including the antibodies used for immunohis-
tochemistry (anti-4.1R E13, anti-4.1R E19, anti-4.1N U1null mice (Fig. 7, panels anti-4.1R E13-E16). Moreover,
the inability of anti-4.1R E13 and anti-4.1R E19 antibod- and anti-4.1B U2), preadsorbed or not with either recom-
binant His-tagged full-length mouse 4.1R (for anti-4.1Ries to detect any protein in 4.1R null kidney extracts
supported that these antibodies were unable to interact E13 and anti-4.1R E19 antibodies), 4.1N (for anti-4.1N
U1 antibody) or 4.1B (for anti-4.1B U2 antibody). Aswith other 4.1 proteins than 4.1R, despite the weak cross-
reactivity of anti 4.1R E13 antibody with recombinant expected, preincubation of 4.1 antibodies with PBS did
not affect detection of renal 4.1 proteins in kidney ex-4.1N, 4.1B, and 4.1G, and that of anti-4.1R E19 antibody
with recombinant 4.1B, respectively (Fig. 2 and Table 1). tracts (Fig. 8). In contrast, detection of kidney 4.1R was
impaired by preincubation of anti-4.1R E13 and anti-The size of the 105 kD isoform resembled that of the
isoform previously described by us in human mammary 4.1R E19 antibodies with recombinant 4.1R, that of kid-
ney 4.1N by preincubation of anti-4.1N U1 antibody withepithelial cells [34], while the 75 kD isoforms were similar
in size to the prototypical red cell 80 kD 4.1R [44]. Blot- recombinant 4.1N, and that of kidney 4.1B by preincuba-
tion of anti-4.1B U2 antibody with recombinant 4.1Bting with a 4.1R antibody, raised against 4.1R unique
region U1 confirmed the absence of this region in the (Fig. 8). Importantly, unlike renal 4.1 proteins, detection
of the 130 kD protein, marked with an asterisk, was not105 kD kidney 4.1R isoform (data not shown). As pre-
viously described [31], we confirmed that kidney 4.1N impaired by any of the preadsorption treatments tested
here (Fig. 8), supporting further our previous conclusionwas a 95 kD protein (Fig. 7, panel anti-4.1N U1). Impor-
tantly, anti-4.1N U1 antibody did not react with kidney that this protein was not a 4.1 protein.
4.1R, despite the weak cross-reactivity of this antibody
Major renal 4.1 protein isoforms can be assigned towith recombinant 4.1R (Table 1). It is also noteworthy
cDNA species of known exon compositionthat kidney 4.1R lacks the U1 region (Fig. 6), the corre-
sponding region in 4.1N used to raise the anti-4.1N U1 Having characterized the major cDNA species ampli-
fied from mouse kidney marathon cDNA (Fig. 6), weantibody (Fig. 1). Protein 4.1B, previously reported to
be expressed in kidney [47], was detected as a doublet investigated whether these cDNA species, expressed as
recombinant proteins in transfected COS-7 cells, wouldof proteins migrating at 108 kD and 105 kD, respectively
(Fig. 7, panel anti-4.1B U2). Although these two kidney match the size of 4.1 proteins expressed in kidney. Be-
cause the recombinant 4.1 proteins were expressed with4.1B isoforms were very similar in size to the major
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Fig. 7. Characterization of renal 4.1 proteins in mouse whole kidney extracts. Western blot analysis of mouse kidney, spleen or brain extracts
(60 g total protein) and of lysates of COS-7 cells transfected with cDNAs encoding hemagglutinin (HA) epitope-tagged mouse kidney 4.1R,
4.1N, or 4.1B splice forms was carried out as described in the Methods section. The 4.1R and 4.1B recombinant proteins displayed on the Western
blot, all initiating at their respective ATG-2 site, are as follows: kidney 4.1R1, 4.1R lacking exon 16 and containing exon 17B-encoded peptides
(major kidney 4.1R isoform); kidney 4.1R2, 4.1R containing exon 16 and exon 17B-encoded peptides; kidney 4.1R3, 4.1R lacking exon 16 and
exon 17B-encoded peptides; kidney 4.1R4, 4.1R containing exon 16 and lacking exon 17B-encoded peptides (red cell 4.1R); kidney 4.1B1, 4.1B
lacking exon 15, exon 17B, and exon 21-encoded peptides (major kidney 4.1B isoform); kidney 4.1B2, 4.1B lacking 54 bp exon 13, exon 15, exon
17B, and exon 21-encoded peptides; and kidney 4.1B3, lacking 54 bp exon 13, exon 15, exon 17, exon 17B, and exon 21-encoded peptides. All
antibodies tested, including rabbit and goat preimmune antibodies (PI rab and PI goat), detected a nonspecific band in wild-type kidney extract
(* on the right side of the bands). Molecular weight markers expressed in kD are shown on the left side of each panel.
a C-terminal HA tag, their molecular weight was ex- to be isoforms initiated at ATG-2, lacking exon 17B,
and either excluding (kidney 4.1R3) or including (kidneypected to be approximately 4 kD higher than that of
the corresponding proteins expressed in vivo [33]. The 4.1R4) exon 16–encoded peptide (Fig. 7, panel anti-4.1R
E13). In contrast to their low level of expression in kid-predicted predominant kidney 4.1R splice form, initiated
at ATG-2 translation site, lacking exon 16, and contain- ney, these75 kD isoforms were expressed at high levels
in spleen (panel anti-4.1R E13). Expression of a cDNAing exon 17B (kidney 4.1R1), when expressed as a recom-
binant protein, closely matched the major 105 kD 4.1R encoding kidney 4.1N splice form (i.e., lacking peptides
encoded by exons 15 and 17D) resulted in a 95 kD pro-isoform detected in kidney (Fig. 7, panel anti-4.1R E13).
Although the isoform, expressing both exons 16 and 17B tein migrating very similarly to the 4.1N isoform detected
in kidney, while the 130 kD recombinant brain 4.1N iso-(kidney 4.1R2), was predicted to be minor from our PCR
screening, detection with our exon 16–encoded peptide form, was not detected in kidney (Fig. 7, panel anti-4.1N
U1), confirming a previous study [31]. Two of the threeantibody showed that this isoform was actually expressed
at significant levels in kidney (Fig. 7, panel anti-4.1R recombinant kidney 4.1B proteins, one initiated at ATG-2
and lacking sequences encoded by exons 15, 17B, andE16). The minor isoforms detected at75 kD were likely
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Fig. 8. Specificity of detection of renal 4.1 proteins in mouse whole kidney extracts. Wild-type mouse whole kidney lysates were probed with anti-
4.1R E13, anti-4.1R E19, anti-4.1N U1, or anti-4.1B U2 antibodies preincubated with either phosphate-buffered saline (PBS) or PBS containing
a 10 mol/L excess of either recombinant histamine (His)-tagged full-length mouse 4.1R, 4.1N, or 4.1B, as described in the Methods section. As
expected, detection of each renal 4.1 protein was ablated when the antibody used to probe the membrane was preadsorbed with the corresponding
recombinant mouse 4.1 protein. Importantly, detection of the 130 kD protein (*) was not affected by any of the preadsorption treatments,
emphasizing that this protein was not a renal 4.1 protein. Molecular weight protein markers expressed in kD are shown on the left of each panel.
21 (kidney 4.1B1), and one also lacking 18 amino acids 4.1G immunostaining in kidney, although it is plausible
that kidney-specific 4.1G splice forms lack the peptideencoded by part of exon 13 (kidney 4.1B2), matched
sequences used to raise 4.1G antibodies. Our RACEthe protein expression profile observed in kidney (i.e.,
experiments, however, do not identify 4.1G transcriptsa doublet of proteins migrating at 108kDa and 105 kD,
lacking such regions, further supporting the specific ab-respectively) (Fig. 7, panel anti-4.1B U2). By contrast,
sence of 4.1G expression in kidney. In addition, othersthe third kidney 4.1B isoform identified by our cDNA
have reported the absence of 4.1G in kidney [47].screening, which also lacked exon 17-encoded peptide
Based on morphologic criteria suggesting a strong(kidney 4.1B3), did not have any counterpart in vivo
4.1R gene promoter activity in the proximal convoluting(Fig. 7, panel anti-4.1B U2).
tubule region of the 4.1R null mouse nephron, we origi-
nally hypothesized that 4.1R would be preferentially ex-
DISCUSSION pressed in the proximal convoluting tubule and likely
The present study provides a detailed description of participate in control of reabsorption [37]. Based on our
the distribution of 4.1 proteins in kidney, at both the current results, the strong 4.1R gene promoter activity
tissue and cellular level. Interestingly, despite the high originally thought to be detected in the proximal convo-
sequence homology of key functional domains in 4.1 luting tubule might actually be in thick ascending limb.
proteins, the proteins show discrete expression patterns Specific expression of 4.1R in the thick ascending limb is
along the nephron. We observed preferential accumula- consistent with a role for 4.1R in regulating reabsorption,
tion of 4.1B in Bowman’s capsule and proximal convo- since thick ascending limb is second to proximal convolu-
luted tubule, of 4.1R in thick ascending limb of Henle’s ting tubule in terms of reabsorption capacity (25% and
loop, and of 4.1N in the thin limb of Henle’s loop, DCT, 65% of overall nephron reabsorption, respectively). In-
and all the regions of the collecting duct system. This terestingly, our preliminary studies have shown that the
likely reflects highly specific roles played by each 4.1 pH of urine collected from 4.1R null mice is significantly
protein in renal structure and function, as has been pre- lower than the pH of urine collected from age matched
wild-type mice subject to a 48 hours of food and waterviously reported for ankyrin [13–15]. We do not identify
Ramez et al: 4.1 family of proteins in the mouse nephron 1335
deprivation (abstract; Gascard P, et al, Mol Biol Cell expression of various membrane kidney transporters
may depend on their interaction with kidney 4.1R, 4.1N,10:154a, 1999). This observation suggests that the ab-
sence of 4.1R may alter function of transporters involved and possibly 4.1B.
Restricted expression of 4.1B to Bowman’s capsulein maintenance of acid/base balance. We also found that
4.1N is expressed in collecting ducts. Collecting duct suggests a potential role for this 4.1 protein in architec-
ture and function of this region of the nephron, a veryepithelium is made of two cell types. Intercalated cells
participate in regulation of urine pH [50], while principal relevant finding given the frequent involvement of this
structure in major nephropathies [62]. Our preliminarycells control water reabsorption through water channels,
known as AQPs [41]. Here, we report the presence of observations suggest presence of 4.1B in parietal epi-
thelial cells. Interestingly, parietal cells display different4.1N in the basolateral membrane of both cell types.
Interestingly, the anion exchanger AE1 has been shown features than podocytes, the cells that surround the glo-
merulus, with respect to morphology, proliferation char-to colocalize with ankyrin and spectrin in the basolateral
region of intercalated cells [51]. Moreover, it has been acteristics, and expression of specific proteins [63, 64].
Future work will further delineate 4.1B localization inrecently established that a mutation in kidney AE1 im-
pairs its trafficking and targeting to the basolateral mem- Bowman’s capsule.
The other highlight of the present study is a detailedbrane, resulting in distal tubular acidosis [52]. Given
that 4.1N has been suggested to adopt also a vesicular characterization of the genetic structure of kidney 4.1R,
kidney 4.1N, and kidney 4.1B. Our PCR experimentsdistribution pattern in kidney [31], it is tempting to specu-
late that 4.1N, along with 4.1R, may participate, along highlight kidney-specific splicing patterns for all 4.1 pro-
tein genes. Translation of all kidney 4.1R isoforms iswith ankyrin and spectrin, in trafficking and anchorage
of membrane transporters and, by doing so, may play a exclusively initiated at the ATG-2 site, with these iso-
forms specifically lacking the U1 region. This finding ismajor role in maintaining urine characteristics, such as
pH and volume. functionally relevant as we have implicated this region
4.1R interacts with red blood cell band 3, also known in modulating 4.1R interactions with binding partners
as AE1 [22–24], and binds in vitro to the cytoplasmic (unpublished data). The major kidney 4.1R isoform ex-
domain of NHE-1 and NHE-2 (Sheryl Denker and Diane cludes exon 16, which encodes both a key component
Barber, UCSF, San Francisco, CA, personal communica- of the SAB domain [39, 49] and a nuclear localization
tion, 2002). Precedent in the published literature for in- signal [25]. This isoform also contains exon 17B-encoded
teractions of proteins related to protein 4.1 with ion peptide, a splicing event restricted to epithelial tissues
exchangers and transporters also exists. Ezrin, a member [34]. 4.1N isoforms also exhibit tissue specificity. A 95 kD
of the protein 4.1 superfamily [21], ensures proper tar- 4.1N isoform is expressed in kidney, whereas a 130 kD
geting of NHE-3 to the apical membrane through its isoform is detected in brain [31]. Evaluation of the func-
interaction with EBP50 [6–11]. The direct association of tional impact of the absence of the two sequences en-
ezrin with NHE-1 is critical for the restricted localization coded by exons 15 and 17D in kidney 4.1N warrants
of NHE-1 within lamellipodia in fibroblasts [12]. An- further study. 4.1B also displays kidney-specific splicing
kyrin, a cytoskeletal protein functionally related to 4.1R, events. First, we report for the first time exclusion of a
interacts with various renal ion transporters to ensure novel exon, similar to exon 2 in 4.1R gene [26], con-
their proper localization at the basolateral pole of the epi- taining the ATG translation initiation site. Initiation of
thelium [19, 53–55]. Thus, once sorted, membrane pro- kidney 4.1B translation at a downstream ATG site, result-
teins are maintained in the appropriate location through ing in the omission of the U1 region, may be as function-
interaction with cytoskeletal proteins such as ezrin, an- ally relevant to 4.1B as it is to 4.1R. Second, we describe
kyrin, and, possibly, protein 4.1. The importance of the exclusion of exon 17B. Finally, we confirm exclusion of
cytoskeleton in maintaining kidney epithelial architec- exons 15 and 21 [33]. Future work will investigate the
ture is illustrated by the observation that renal ischemia, structural and functional impact of the absence of these
which results in proteolysis of ankyrin and spectrin, leads various peptides in kidney 4.1 proteins.
to a major disorganization of kidney epithelial polarity
[56]. Interestingly, we have observed that red blood cells
CONCLUSIONfrom 4.1R null mice showed a dramatic decrease in glyco-
We conclude that members of the protein 4.1 genephorin C content [37], a transmembrane protein known
family are only expressed in distinct regions of the neph-to interact with 4.1R [57–60]. 4.1N interacts with a sub-
ron but also show differential subcellular distribution.unit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole-
We speculate that 4.1 proteins, like ankyrins, may playpropionate glutamate receptor in brain, this interaction
unique roles in renal structure and function. Future in-being necessary not only for proper targeting of the re-
vestigation of the roles of 4.1 proteins in kidney functionceptor but also for its level of expression [61]. Thus,
not only proper membrane localization but also level of will be based on the characterization of renal 4.1 isoforms
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